Connection of Body Posture From the Level and Form of Physical Activity in a Group of Young People

December 5, 2022 updated by: Medical University of Silesia

Assessment of Body Posture Connection From the Level and Form of Physical Activity in a Group of Young People

The assumption of the research is to assess the change in body posture depending on the given level of physical activity in young people. The aim of the study is to assess body posture in young healthy people depending on their level of physical activity. The research will allow the analysis of the correlation between the level of energy expenditure and the occurrence of changes in body posture. The obtained results will allow the development of diagnostic and therapeutic programs for the prevention of overload changes in the spine in young people.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

The study will be conducted in a group of 200 people aged 19-25. Posture assessment will concern the measurement of curvatures in the sagittal plane of the spine using a gravitational Rippstein plurimeter and performing a three-dimensional analysis of the spine using the DIERS 3D device. In addition, a modified Matthias test will be performed using the DIERS 3D device, where kyphosis and lordosis parameters in the sagittal plane of the spine at isometric tension of the spinal muscles will be assessed. The spinal motion in the sagittal and frontal planes will also be measured using a digital inclinometer. In the second stage of the study, the participants will participate in the activity in the form of endurance training "Nordic Walking" (NW) for a period of 8 weeks 3 times a week. The recording of energy expenditure during a normal day of activity will be done using an Actigraph GT3X accelerometer. After a period of 8 weeks, all measurements will be repeated.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Anticipated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

  • Name: Bartosz Wnuk, PhD PT
  • Phone Number: +48 32 252 43 70
  • Email: bwnuk@sum.edu.pl

Study Locations

  • Poland
    • Katowice Ochojec
      • Katowice,, Katowice Ochojec, Poland, 40-635
        • Recruiting
        • The Department of Rehabilitation, Faculty of Health Sciences in Katowice, Medical University of Silesia, Katowice,
        • Contact:
        • Sub-Investigator:
          • Bartosz Wnuk, Ph.D.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

19 years to 25 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Students of Medical University of Silesia in Katowice, Poland

Description

Inclusion Criteria:

  • age from 19 to 25 years old
  • good health enabling the exercise of various forms of physical effort -cardiologically stable persons, without significant respiratory, nervous and musculoskeletal disorders / no other diseases
  • written consent of the examined person

Exclusion Criteria:

  • age below 19 and above 25,
  • health condition preventing the exercise of various forms of physical effort (cardiologically unstable persons with significant respiratory, nervous and musculoskeletal disorders / other diseases that prevent physical activity,
  • lack of written consent of the examined person,
  • lack of cooperation of the examined person during the test

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Group A1 male
back shape neutral - a vertical line applied to the back of the body meets at the level of the thoracic segment and buttocks
Diagnostic test: examining group
Posture assessment in young healthy people depending on their level of physical activity
Group A2 female
back shape neutral - a vertical line applied to the back of the body meets at the level of the thoracic segment and buttocks
Diagnostic test: examining group
Posture assessment in young healthy people depending on their level of physical activity
Group B1 male
round back shape - a vertical line applied to the back of the body contacts only at the level of the thoracic segment
Diagnostic test: examining group
Posture assessment in young healthy people depending on their level of physical activity
Group B2 female
round back shape - a vertical line applied to the back of the body contacts only at the level of the thoracic segment
Diagnostic test: examining group
Posture assessment in young healthy people depending on their level of physical activity
Group C1 male
round back shape - a vertical line applied to the back of the body only touches the level of the buttock section
Diagnostic test: examining group
Posture assessment in young healthy people depending on their level of physical activity
Group C2 female
round back shape - a vertical line applied to the back of the body only touches the level of the buttock section
Diagnostic test: examining group
Posture assessment in young healthy people depending on their level of physical activity

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Body posture parameters assessed:
Time Frame: 9 weeks
  • Rippstein plurimeter - measurement of curvature of the spine - kyphosis, lordosis and measurement of the range of spinal mobility in the frontal and transverse planes (ROM)
  • formetric measurement using the DIERS 3D three-dimensional analysis system-tilt of the torso, pelvic lift, pelvic rotation ,pelvic tilt, kyphosis angle, lordosis angle, spine rotation ,side deviation
  • assessment of spinal flexibility (measuring device - digital inclinometer) - range of spinal mobility in the frontal and sagittal plane (ROM)
9 weeks
Physical activity parameters assessed:
Time Frame: 9 weeks
accelerometer ActiGraph GT3X - assessment of MET energy expenditure and the number of steps performed during one day
9 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Medical University of Silesia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 16, 2022

Primary Completion (Anticipated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
January 27, 2023

Study Completion (Anticipated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
February 24, 2023

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 1, 2020

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 10, 2020

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 13, 2020

Study Record Updates

Last Update Posted (Estimate)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
December 6, 2022

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
December 5, 2022

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2022

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • BW- 2020- SUM

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Body Posture

Clinical Trials on examining group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings